Clinical Trial Update: Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses a dose-dense regimen of carboplatin, docetaxel, and trastuzumab as initial systemic therapy for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Miami | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-08-21